Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Comparative Study of the Tomey FT-1000, and Goldmann Applanation Tonometer (GAT)

3. september 2026 oppdatert av: Tomey Corporation

This study is intended to evaluate the agreement between Intraocular pressure(IOP) measurements obtained with the FT-1000 non-contact tonometer and a GAT to confirm the feasibility of the measurement procedures.

This is a prospective comparative study that will be conducted at one clinical site in the United States. Subjects who sign an informed consent form and fulfill all inclusion and exclusion criteria will undergo FT-1000 measurements followed by Goldmann applanation tonometry during a single study visit.

The primary analysis will be performed using one preselected study eye from each subject. Measurements from the fellow eye, when available, may be summarized as exploratory analyses but will not contribute to the primary effectiveness analysis.

In general, descriptive statistics (n, mean, standard deviation, median, minimum and maximum) will be used to summarize continuous variables. Frequencies and percentages will be used to summarize categorical variables. The number of accepted scans and the total number of scans evaluated will be summarized by scan type, device, and subject population.

Agreement between the FT-1000 and the Goldmann applanation tonometer will be evaluated using the study eye measurements by calculating the mean difference, standard deviation (SD), 95% limits of agreement (LOA), Bland-Altman plots, Deming regression, and Pearson correlation coefficient.

Exploratory analyses may also be performed using fellow-eye measurements.

Studieoversikt

Status

Har ikke rekruttert ennå

Forhold

Studietype

Observasjonsmessig

Registrering (Antatt)

30

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Low Intraocular pressure(IOP) (22 years old or older) Middle Intraocular pressure(IOP)(22 years old or older) High Intraocular pressure(IOP)(22 years old or older)

Beskrivelse

Inclusion Criteria:

  1. Male or female subjects 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed.
  2. Subjects who are able to understand and follow the study procedures and instructions provided by the clinical staff.
  3. Subjects who voluntarily provide written informed consent.
  4. Subjects who satisfy all study eligibility requirements and are able to undergo both FT-1000 and Goldmann applanation tonometry measurements during the study visit.

Exclusion Criteria:

  1. Subjects with only one functional eye.
  2. Subjects with poor or eccentric fixation in either eye.
  3. Subjects with a history of corneal surgery, including corneal laser or refractive surgery (e.g., LASIK).
  4. Subjects with corneal scarring, keratoconus, or any other clinically significant corneal pathology.
  5. Subjects with an active corneal or conjunctival infection or inflammation in either eye.
  6. Subjects with microphthalmos or buphthalmos.
  7. Subjects who are unable or unwilling to remove contact lenses before study measurements.
  8. Subjects with clinically significant dry eye disease that, in the investigator's opinion, may affect tonometry measurements.
  9. Subjects with blepharospasm (lid squeezing) or nystagmus that may interfere with accurate measurements.
  10. Subjects with abnormal central corneal thickness (CCT).
  11. Subjects with any condition or circumstance that, in the opinion of the investigator, could place the subject at significant risk, interfere with study participation, or confound interpretation of the study results.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Low Intraocular pressure(IOP) Group: 7-16 mmHg
Group with IOP of 7-16 mmHg; 10 subjects.
Intraocular pressure measurement by non-contact tonometer and applanation tonometer.
Middle Intraocular pressure(IOP) Group: >16 to <23 mmHg
Group with IOP of >16 to <23 mmHg; 10 subjects.
Intraocular pressure measurement by non-contact tonometer and applanation tonometer.
High Intraocular pressure(IOP)Group: ≥23 mmHg
Group with IOP of ≥23 mmHg; 10 subjects.
Intraocular pressure measurement by non-contact tonometer and applanation tonometer.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Safety of the test devices
Tidsramme: Through study completion, approximately 3 days
Any adverse events observed or reported during the study visit will be assessed and documented.
Through study completion, approximately 3 days
Agreement of the Intraocular pressure (IOP) mmHg between the test devices and predicate device
Tidsramme: Through study completion, approximately 3 days

Agreement of the Intraocular pressure (IOP) mmHg between the FT-1000 and the Goldmann Applanation Tonometer(GAT) will be evaluated using the study eye measurements by calculating the mean difference, standard deviation (SD), 95% limits of agreement (LOA), Bland-Altman plots, Deming regression, and Pearson correlation coefficient.

Exploratory analyses may also be performed using fellow-eye measurements.

Through study completion, approximately 3 days

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

24. september 2026

Primær fullføring (Antatt)

28. september 2026

Studiet fullført (Antatt)

28. september 2026

Datoer for studieregistrering

Først innsendt

31. august 2026

Først innsendt som oppfylte QC-kriteriene

31. august 2026

Først lagt ut (Faktiske)

4. september 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

9. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

3. september 2026

Sist bekreftet

1. august 2026

Mer informasjon

Begreper knyttet til denne studien

Ytterligere relevante MeSH-vilkår

Andre studie-ID-numre

  • TomeyFT-1000-001

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Ja

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere